@article{AMJ3701,
author = {Andrea Mancuso},
title = {Regorafenib for hepatocellular carcinoma progressing on sorafenib: just another starting point},
journal = {AME Medical Journal},
volume = {2},
number = {3},
year = {2017},
keywords = {},
abstract = {Hepatocellular carcinoma (HCC) is the second most common cause of death from cancer worldwide and a major global health problem. The incidence of HCC increases progressively with advancing age, reaching a peak at 70 years. Moreover, there is a growing incidence of HCC worldwide (1).},
issn = {2520-0518}, url = {https://amj.amegroups.org/article/view/3701}
}